Zusammenfassung
Morphologische und immunhistochemische Kriterien führen innerhalb der Kiel-Klassifikation zur Differenzierung zwischen der chronischen lymphatischen Leukämie (B-CLL) und dem Immunozytom (Lennert u. Feller 1992). Für die klinische und prognostische Bedeutung dieser Unterteilung sprechen die Ergebnisse einer prospektiven, multizentrischen Beobachtungsstudie (Brittinger et al. 1984, 1985; Engelhard et al. 1991). Das Immunozytom subsumiert die früher als nosologische Einheit betrachtete Makroglobulinämie Waldenström sowie Erkrankungsformen, die vor der Erarbeitung der Kiel-Klassifikation klinisch-prognostisch als „atypische“ chronische lymphatische Leukämie imponierten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Bagley CM, DeVita jr VT, Berard CW, Canellos GP (1972) Advanced lyphosarcoma: Intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med 76: 227-234
Barlogie B, Smith L, Alexanian R (1984) Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med 310: 1353 - 1356
Beutler E (1994) New chemotherapeutic agents: 2-Chlorodeoxyadenosine. Semin Hematol 31: 40 - 45
Binet JL (1993) Treatment of chronic lymphocytic leukaemia. In: Bailliére’s Clinical Haematology. International Practice and Research, vol 6/no 4. Bailliéere Tindall, London Philadelphia Sydney Tokyo Toronto, pp 867 - 878
Binet JL, Catovsky D, Chandra P, Dighiero G, Montserrat E, Rai KR, Sawitsky A (1981) Chronic lymphocytic leukaemia: Proposals for a revised prognostic staging system. Report from the International Workshop on CLL. Br J Haematol 48: 365-367
Brittinger G, Bartels H, Common H et al. (1984) Clinical and prognostic relevance of the prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 2: 269 - 306
Brittinger G, Meusers P, Musshoff K, Gyenes T (1985) Non-Hodgkin-Lymphome und Plasmozytom. In: Gross R, Schmidt CG (Hrsg) Klinische Onkologie. Thieme, Stuttgart New York, pp 41.0-41. 81
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31: 1860 - 1861
Carde P, Burger JMV, Glabbeke M van, Hayat M, Cosset JM, Somers R (1984) Combined radiotherapy for early stages non-Hodgkin’s lymphoma: The 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol Biol Phys 6: 125 - 134
Chabner BA, Bates SE, Fojo AT, Spolyar M, Wilson WH (1994) Drug resistance in adult lymphomas. Semin Hematol 31: 70 - 87
Cheson BD, Bennett JM, Rai KR et al. (1988) Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute-sponsored Working Group. Am J Hematol 29: 152-163
Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia (1988) Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. N Engl J Med 319: 902 - 907
Dillman RO (1994) A new chemotherapeutic agent: Deoxycoformycin (pentostatin). Semin Hematol 31: 16 - 27
Dimopoulos MA, O’Brien S, Kantarjian H et al. (1993) Fludarabine therapy in Waldenström’s macroglobulinemia. Am J Med 95: 49 - 52
Engelhard M, Brittinger G, Heinz R et al. (1991) Chronic lymphocytic leukemia (BCLL) and immunocytoma (LP-IC): Clinical and prognostic relevance of this distinction. Leukemia and Lymphoma [Suppl]: 161 - 173
Epelbaum R, Kuten A, Coachman NM et al. (1992) Stage I-II low grade non-Hodgkin’s lymphoma: Prognostic factors and treatment results. Strahlenther Onkol 168: 66-72
French Cooperative Group on Chronic Lymphocytic Leukaemia (1986) Effectiveness of „CHOP” regimes in advanced untreated chronic lymphocytic leukaemia. Lancet I: 1346 - 1349
Gale RP, Montserrat E (1993) Intensive therapy of chronic lymphocytic leukaemia. In: Bailliére’s Cliniucal Haematology. International Practice and Research, vol6/no 4. Bailliére Tindall, London Philadelphia Sydney Tokyo Toronto, pp 879 - 885
Gandhi V, Kemena A, Keating MJ, Pluinkett W (1992) Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia. Cancer Res 52: 897 - 903
Grossbard ML, Press OW, Appelbaum FR, Bernstein ID, Nadler LM (1992) Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 80: 863 - 878
Karnofsky DA, Burchenal JH (1948) The evaluation of chemotherapeutic agents against neoplastic disease. Cancer Res 8: 388 - 389
Keating MJ, O’Brien S, Plunkett W et al. (1994) Fludarabine phosphate: A new active agent in hematologic malignancies. Semin Hematol 31: 28-39
Kempin S, Lee BH III, Thaler HT et al. (1982) Combination chemotherapy of advanced chronic lymphocytic leukemia. The M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan and prednisone ). Blood 60: 1110-1121
Knospe WH, Loeb jr V, Huguley jr CM (1974) Biweekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 33: 555 - 562
Landys KE (1987) Mitoxantrone in combination with prednimustine in treatment of unfavorable non-Hodgkin’s lymphoma. Blut 55: 328
Lawrence TS, Urba WJ, Steinberg SM, Sundeen JT, Cossman J, Young RC, Glatstein E (1988) Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute. Int J Radiat Oncol Biol Phys 14: 417 - 424
Lennert K, Feller AC (eds) (1992) Histopathology of non-Hodgkin’s lymphomas (based on the updated Kiel classifikation), 2nd edn. Springer, Berlin Heidelberg New York Tokyo
McKelvey EM, Gottlieb JA, Wilson HE et al. (1976) Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38: 1484 - 1493
Montserrat E, Alcala A, Parody R et al. (1985) Treatment of chronic lymphocytic leukemia in advanced stages: A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine and prednisone. Cancer 56: 2369-2375
Musshoff K, Schmidt-Vollmer H (1975) Prognosis of non-Hodgkin’s lymphomas with special emphasis on the staging classification. Z Krebsforsch 83: 323 - 341
Paule B, Cosset JM, Le Bourgois JP (1985) The possible role of radiotherapy in chronic lymphocytic leukaemia: A critical review. Radiother Oncol 4: 45-54
Piro LD, Carrera CJ, Beutler E, Carson DA (1988) Chlorodeoxyadenosine. An effective new agent for the treatment of chronic lymphatic leukemia. Blood 72: 1069-1073
Rabinowe SN, Grossbard ML, Nadler LM (1993) Innovative treatment strategies for chronic lymphocytic leukemia: Monoclonal antibodies, immunoconjugates, and bone marrow transplantation. In: Cheson BD (ed) Chronic lymphocytic leukemia: Scientific advances and clinical developments. Dekker, New York, pp 337 - 367
Rai KR, Rabinowe SN (1993) Chronic lymphocytic leukemia. In: Holland IF, Frei III E, Bart RC, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer medicine, vol II, 3rd edn. Lea & Febiger, Philadelphia London, pp 1971 - 1988
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219 - 234
Sawitsky A, Rai KR, Glidewell O et al. (1977) Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 50: 1049 - 1059
Taylor RE, Allan SG, McIntyre MA, Kerr GR, Talor AJ, Ritchie GL, Leonard RCF (1988) Low grade stage I and II non-Hodgkin’s lymphoma: Results of treatment and relapse pattern following therapy. Clin Radiol 39: 287-290
Theml H, Burger A, Keiditsch E et al. (1977) Beobachtungen zur Charakterisierung des splenomegalen Immunozytoms. Med Klin 72: 1019 - 1032
Yahalom J, Varsos G, Fuks Z, Myers J, Clarkson BD, Straus DJ (1993) Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospectice randomized study. Cancer 71: 2342-2350
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Meusers, P., Brittinger, G., Bamberg, M. (1997). Immunozytom (lymphoplasmozytisches/lymphoplasmozytoides Lymphom). In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-12175-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60830-1
Online ISBN: 978-3-662-12175-7
eBook Packages: Springer Book Archive